← Eichor
Study identifier: NCT06727110 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Polymer Induced Liquid Precursor (PILP) in Adults in With Dentin Caries

Condition: Dental Caries  ·  Sponsor: University of California, San Francisco

PhaseNA
Planned participants30
Who can joinAll sexes, 18 Years to 64 Years
Healthy volunteersNo

About this study

The goal of this clinical trial is to learn if polymer-induced liquid precursor (PILP) can be used safely to treat dentin caries (cavities) in adults. The main question it aims to answer is: Is PILP (conditioner or liner) safe in adult teeth with dental caries? Researchers will compare PILP to a placebo (a look-alike substance that contains no drug) to see if PILP safely treats cavities in teeth. Participants will: 1) Have PILP or placebo applied to their tooth prior to the placement of a filling in the tooth, 2) Complete two telephone calls within three months of filling placement and 3) Visit the clinic at three months and six months after the placement of the filling.

This description comes directly from the study's public registry record.

Talk to the study team

Jean Star, DDS, MPH  ·  415-514-9768  ·  jean.star@ucsf.edu

Jessica Snider, MBA  ·  4155146994  ·  jessica.snider@ucsf.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of California San Francisco, School of DentistrySan Francisco, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06727110